NCT03509441View on ClinicalTrials.gov

Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

January 15, 2015

Primary Completion Date

September 11, 2019

Study Completion Date

November 11, 2019

Conditions
CardiomyopathiesInsulin ResistanceNon-ischemic CardiomyopathyCardiac FibrosisDiabetes
Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03509441 - Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance | Biotech Hunter | Biotech Hunter